Isdin Eryfotona AK-NMSC Fluid SPF100+ is a medical device for the prevention and adjuvant protective treatment of actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC). It creates a film on the skin with DNA Repairsomes® that prevents new lesions, reducing and improving the subclinical skin cancer field (the cancer field corresponds to the area of skin with subclinical lesions not yet visible, which may be surrounding each actinic keratosis).
Prevention and adjuvant protective treatment of actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC);
Reduces and improves the associated subclinical skin cancerization field;
Creates a film on the skin of DNA Repairsomes® that absorbs, reflects and disperses solar radiation;
Its light texture blends into the skin and is easy to apply.
Apply generously to the entire affected area and other areas at risk of chronic sun exposure, such as the face, forehead, ears, décolleté, scalp and back of the hands.
Twice a day: morning and noon.
Daily use.
Photolyase is activated by visible light.
In case of direct sun exposure, reapply the product every two hours.
Prevention and adjuvant protective treatment of actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC).
Reduces and improves the field of subclinical cutaneous carcinogenesis associated with actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC).
Precautions: Actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC) are caused by chronic exposure to sunlight. If you have had AK or another form of NMSC, you should avoid direct sunlight. There are no data regarding the use of Eryfotona AK-NMSC in children, pregnant women, or breastfeeding women.
Avoid contact with eyes and mucous membranes.
If you experience an adverse reaction to any of the ingredients, stop treatment and consult your doctor.
Keep out of reach and sight of children.
Shake before use.
